Global Anal Fissure Therapeutics Market - 2022-2029

Market Overview

The global anal fissure therapeutics market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029).

An anorectal condition marked by inflammation or tearing of the lining of the lower rectum is known as an anal fissure. During bowel movements, it causes considerable discomfort and blood. The ailment is not life-threatening, but it has a major impact on a person's quality of life.

Market Dynamics

The factors driving the growth of the anal fissure treatment market include increasing cases of of constipation, growing adoption of a sedentary lifestyle, and consumption of spicy, saturated, and trans-fat foods. Furthermore, the advent of novel treatments and increased awareness of anorectal illnesses are factors influencing the growth of this market.

Rising cases of aquired immunodeficiency syndrome will drive the market growth

Growing awareness of various treatment choices, advancements in medications and surgical processes like laser therapy, and a reduction in the social stigma associated with its treatment contribute to the market's expansion. Rising TB cases, cancer, an acquired immunodeficiency syndrome (AIDS), and inflammatory bowel disease. Furthermore, hormonal changes in pregnant women promote constipation, which leads to anal fissures. Anal fissures can also be caused by childbirth stress. Other risk factors include anal sex, ulcerative colitis, and Crohn's disease.

According to UNAIDS, In 2020, there will be roughly 37.7 million HIV-positive people worldwide. There were 36 million adults and 1.7 million children aged 0-14 years. More than half (53%) were females and girls.Moreover, In 2015, an estimated 1.3 percent of adults in the United States (3 million) were diagnosed with IBD (either Crohn's disease or ulcerative colitis). This was a significant rise over 1999. (0.9 percent or 2 million adults).(Source: Centre for Disease Control and Prevention).

Moreover, Constipation is common among Americans. Constipation affects almost everyone at some point in their lives, with a recent poll revealing that 16% of Americans and one-third of those over 60 suffer from chronic constipation.(Source:Statnews). These factors are likely to boost the anal fissure therapeutics market.

Harmful effects of medications is likely to hamper the market growth

Nonetheless, the harmful effects of medications like headaches, dizziness, itching, or burning at and the increased rate of treatment-seeking are the factors impeding the growth of this market.

COVID-19 Impact Analysis

The global market for anal fissure therapeutics has been impacted due to COVID-19 outbreak. The pandemic has hampered progress in several countries across multiple disciplines. The COVID-19 outbreak continued to harm important major participants in the anal fissure treatment industry. However, many producers are struggling due to supply chain delays caused by lockdown in various nations in the third quarter. However, the negative impact is being partially compensated in several ways, such as utilizing numerous distribution alternatives and online channels.

Segment Analysis

The calcium channel blockers segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

By treatment, the market is divided into nitrate ointment, calcium channel blockers, botox injections and others. Calcium channel blockers are going to boost in the forecast period.Calcium channel blockers are antihypertensive medicines. They function by blocking calcium from entering the heart and artery cells. Calcium causes the heart and arteries to constrict more tightly. Calcium channel blockers allow blood arteries to relax and open by inhibiting calcium. Infants and middle-aged people are the most commonly affected by anal fissures. Every year, around 235,000 new cases of an anal fissure are reported in the United States.(Source: Uptodate).

Geographical Analysis

North America region holds the largest market share of the global anal fissure therapeutics market

The North American anal fissure therapeutics market accounted for the maximum share because of the widespread use of advanced treatment. Another significant market driver is the high rate of blockage among patients. According to the American Gastroenterological Association, about 60% of Americans suffer from this illness. Medicines required for rapid recovery are likely to accelerate the growth of the anal fissure treatment market.

North American region is developing novel treatment alternatives. Furthermore, rising death rates increased patient awareness about the disease. Advanced healthcare infrastructure is expected to drive the growth of the anal fissure therapeutics market in North America.

Competitive Landscape

The anal fissure therapeutics market is a highly competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Takeda Pharmaceuticals, Manus Aktteva, Pfizer, AbbVie, Pfizer, Farmacosmo, Silvergate Pharmaceuticals, Covis Pharmaceuticals, Novartis AG, Trumachealthcare, Taj Pharmaceuticals, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the anal fissure therapeutics market globally. For instance, in Februray 2021, Takeda Files New Drug Application in Japan to Manufacture and Market Darvadstrocel for the Treatment of Complex Perianal Fistulas in Adult Crohn's Disease Patients

Taj Pharmaceuticals Limited

Overview:

Taj Pharmaceuticals Limited is a pharmaceutical company that manufactures and sells medications. Prescription solutions, lifesaving pharmaceuticals, anti-cancer drugs, veterinary products, consumer brands, and CNS drugs are among the company's offerings. It focuses on anemia, anxiety disorders, cancer/oncology, ear infections, heart failure, hepatitis, HIV/AIDS, influenza, non-lymphoma, Hodgkin's obesity, osteoporosis, Parkinson's disease, pneumonia, transplantation, and widespread diseases. The Taj Pharmaceuticals India Business is based in Mumbai, India.

Product Portfolio:

Nitroglycerin ointment: Nitroglycerin ointment is an excellent treatment for anal fissure because many patients prefer to forgo surgery; Glyceryl trinitrate topical treatment has been shown in studies to reduce maximum anal resting pressures in patients with a range of anal pathologies. As a result, anal fissure repair occurs in many patients than in the control group.

Why Purchase the Report?

Visualize the composition of the global anal fissure therapeutics market segmentation by treatment, route of administration, distribution channel, and region highlighting the key commercial assets and players.

Identify commercial opportunities in the global anal fissure therapeutics market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global anal fissure therapeutics market-level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global anal fissure therapeutics market report would provide access to an approximately 40+ market data table, 45+ figures, and in the range of 190 (approximate) pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Anal Fissure Therapeutics Market- By Treatment

Nitrate Ointment

Calcium Channel Blockers

Botox Injections

Others

Global Anal Fissure Therapeutics Market- By Route of Administration

Oral

Topical

Others

Global Anal Fissure Therapeutics Market- By Distribution Channel

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Global Anal Fissure Therapeutics Market- By Region

North America

Europe

Asia-Pacific

Middle East & Africa

South America